AS
VCYT icon

Altshuler Shaham’s Veracyte VCYT Stock Holding History

Altshuler Shaham’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-813
Closed -$44K – 748
2021
Q1 		$44K Buy
813
+225
+38% +$13K ﹤0.01% 305
2020
Q4 		$29K Buy
+588
New +$27.2K ﹤0.01% 330
2019
Q3 		– Sell
-434
Closed -$12K – 563
2019
Q2 		$12K Buy
434
+29
+7% +$724 ﹤0.01% 266
2019
Q1 		$10K Buy
+405
New +$7.73K ﹤0.01% 243
2018
Q4 		– Sell
-612
Closed -$6K – 306
2018
Q3 		$6K Buy
+612
New +$6.75K ﹤0.01% 238

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altshuler Shaham's VCYT Position: Q2 2021 in Review

Altshuler Shaham sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 813 shares — an estimated $44K sold.

Altshuler Shaham first reported a position in VCYT in Q3 2018 and held it in 5 quarters. The position peaked at $44K in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Altshuler Shaham reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Altshuler Shaham sold 813 Veracyte shares in Q2 2021, an estimated $44K.
  • Altshuler Shaham first reported a position in Veracyte in Q3 2018 and held it in 5 quarters.
  • Altshuler Shaham's Veracyte position peaked at $44K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Altshuler Shaham's 13F filing for Q2 2021, filed 16 Aug 2021.